medigraphic.com
Federación Mexicana de Ginecología y Obstetricia, A.C.

2009, Number 01

<< Back Next >>

Ginecol Obstet Mex 2009; 77 (01)

Diagnosis of infection Chlamydia trachomatis by PCR among patients in the Specialty Clinic of Women of the National Defense Secretary

Sánchez MV, Torres MAE, Villalba MJDA

Language: Spanish
References: 20
Page: 13-18
PDF size: 79.58 Kb.


ABSTRACT

Introduction: Infection with Chlamydia trachomatis is a sexually transmitted bacterial disease most common in the world.
Material and Methods: Determination through the PCR technique the presence of C. trachomatis in 98 cervical samples by amplifying a fragment of DNA plasmid cryptic. We investigated medical variables of interest and contraceptive methods in the population. Variables were compared between the positive and negative patients to infection with C. trachomatis using the test of Mann-Whitney U test and Chi square with the program SigmaStat version 2.0. We considered statistically significant as those values of p ‹0.001.
Results: 20 samples were found positive for infection with C. trachomatis of the 98 patients studied, indicating a prevalence of 20.4% of the total group. The variables analyzed showed a statistically significant difference in the number of abortions, which were higher for patients positive for the infection.
Conclusions: The prevalence found in this study suggests that infection with C. trachomatis is an issue of concern in public health, it requires the count on diagnostic techniques, such as PCR favoring an increase in the detection and early treatment in reducing the spread of the infection and long-term sequelae, so that justifies his provide detection in a broader way.


REFERENCES

  1. Cates W, Wasserheit JN. Genital chlamydial infection: Epidemiology and reproductive sequelae. Am J Obstet Gynecol 1991;164:1771-81.

  2. Sieper J, Kingsley G. Recent advances in the pathogenesis of reactive arthritis. Immunol Today 1996;17:160-2.

  3. Whitcher JP, Srinivasan M, Upadhyay MP. Corneal blindness a global perspective. Bulletin of the World Health Organization 2001;79:214-21.

  4. Jalal H, Stehen H, Bibby DF, Sonnex C, Carne CA. Molecular epidemiology of genital human papillomavirus and Chlamydia trachomatis among patients attending a genitourinary medicine clinic- will vaccines protect? Int J STD AIDS 2007;18:617-21.

  5. Giuliano A, Denman C, Guernsey de Zapien J, Navarro HJ, et al. Design and results of the USA-Mexico border human papillomavirus (HPV), cervical dysplasia, and Chlamydia trachomatis study. Rev Panam Salud 2001;9:172-81.

  6. Rowe PJ. Reproductive tract infectious: Annual Technical Report. Human Reproduction Programme, WHO; 1998;pp:186-90.

  7. Reyes ME, Díaz FLA, Gonzalez BCV, Esquer MM, et al. Detection of Chlamydia trachomatis by immunofl uorescence, Papanicolaou and immunoperoxidase in woman with leucorrhea. Rev Latinoam Microbiol 1996;38:65-73.

  8. Acosta CB, Ruiz ML, Escobedo PJ. Prevalence and risk factors for Chlamydia trachomatis infection in low-income rural and suburban populations of Mexico. Sex Transm Dis 1996;23:283-88.

  9. Iglesias BJ, Saldivar RD, Tijerina MR, González GG, y col. Chlamydia trachomatis y Neisseria gonorrhoeae: prevalencia y relación con los datos clínicos de vaginitis. Medicina Universitaria 2007;9:53-7.

  10. Canto DT, Polanco RL, Fernández GV, Ruiz GS. Infección por Chlamydia trachomatis en usuarias de dos clínicas de planifi - cación familiar. Salud Pública Méx 2003;45 supl 5:S657-61.

  11. Jiménez PT, Trujillo OL, Roblero OS. Prevalencia de Chlamydia trachomatis en mujeres usuarias de un hospital general en Tuxtla Gutiérrez, Chiapas. Enf Infec y Micro 2001;21:123-5.

  12. Cravioto MC, Matamoros O, Villalobos ZY, Peña O, y col. Prevalencia de anticuerpos anti-Chlamydia trachomatis y anti- Neisseria gonorrhoeae en grupos de individuos de la población mexicana. Salud Pública Méx 2003; 45 Supp 5:S681-9.

  13. Bañuelos PC, Deleon RI, Hernandez MJ, Martinez GL, et al. Detection of Chlamydia trachomatis in pregnant women by the Papanicolaou technique, enzyme immunoassay and polymerase chain reaction. Acta Cytol 2000;44:114-23.

  14. Díaz BG, Díaz LE, Servin RF. Frecuencia de Chlamydia trachomatis en el cervix de mujeres embarazadas en control prenatal. Ginecol Obstet Mex 1997;65:48-52.

  15. Rosas AJ, Toca PL, Díaz EC, Nava FJ. Infección por Chlamydia trachomatis en cérvix uterino. Ginecol Obstet Mex 1993;61:326-8.

  16. Esquivel CA, Briones EML, Castruita LD, Lazalde RB, et al. Prevalence of Chlamydia trachomatis infection in registered female sex workers in northern Mexico. Sex Transm Dis 2003;30:195-8.

  17. Mahony JB, Luinstra KE, Chernesky MA. Detection of Chlamydia trachomatis DNA in culture positive and culture negative specimens by polymerase chain reaction (PCR). Eighth ISSTDR Meeting Copenhagen, Denmark 1989, Abstract # 20.

  18. Mahony JB, Luinstra KE, Sellors JW, Chernesky MA. Comparation of plasmid –and Chromosome-Based polymerase chain reaction assays for Detecting Chlamydia trachomatis Nucleic Acids. J Clin Microbiol 1993; 31:1753-8.

  19. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning. A laboratory manual. 3th ed. New York: Cold Spring Harbor Press, 1994.

  20. Marrazzo JM, Cellum CL, Hillis SD, Fine D, et al. Performance and cost-effectiveness of selective screen criteria for Chlamydia trachomatis infection in women. Sex Transm Dis 1997;24:131-41.




2020     |     www.medigraphic.com